Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trialRobert Bowser, Jiyan An, Lahar Mehta, Junliang Chen, Jamie Timmons, Merit Cudkowicz, Sabrina Paganoni
2 December 2023
CSF sphingolipids are correlated with neuroinflammatory cytokines and differentiate neuromyelitis optica spectrum disorder from multiple sclerosisLisa Shi, Laura Ghezzi, Chiara Fenoglio, Anna Margherita Pietroboni, Daniela Galimberti, Francesca Pace, Todd A Hardy, Laura Piccio, Anthony S Don
6 June 2024
Dynamics of synaptic damage in severe traumatic brain injury revealed by cerebrospinal fluid SNAP-25 and VILIP-1Florian olde Heuvel, Zhenghui Li, Daniel Riedel, Steffen Halbgebauer, Patrick Oeckl, Benjamin Mayer, Nina Gotzman, Sandy Shultz, Bridgette Semple, Hayrettin Tumani, Albert C Ludolph, Tobias Maria Boeckers, Cristina Morganti-Kossmann, Markus Otto, Francesco Roselli
2 June 2024
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancySandra Thiel, Nastassja Litvin, Sabrina Haben, Ralf Gold, Kerstin Hellwig
19 December 2023
Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer’s diseaseVijay Patel, Paul Edison
30 January 2024
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated diseaseGanesha Liyanage, Benjamin P Trewin, Joseph A Lopez, Jane Andersen, Fiona Tea, Vera Merheb, Kristy Nguyen, Fiona X Z Lee, Marzena J Fabis-Pedrini, Alicia Zou, Ali Buckland, Anthony Fok, Michael H Barnett, Stephen W Reddel, Romain MarignierSee the full list of authors
30 January 2024
Head trauma results in manyfold increased risk of multiple sclerosis in genetically susceptible individualsEva Johansson, Lars Alfredsson, Pernilla Strid, Ingrid Kockum, Tomas Olsson, Anna Karin Hedström
11 January 2024
Cognitive trajectory in the first year after first-ever ischaemic stroke in young adults: the ODYSSEY studyMijntje M I Schellekens, Ravi C S Springer, Esther M Boot, Jamie I Verhoeven, Merel S Ekker, Mayte E van Alebeek, Paul J A M Brouwers, Renate M Arntz, Gert W van Dijk, Rob A R Gons, Inge W M van Uden, Tom den Heijer, Julia H van Tuijl, Karlijn F de Laat, Anouk G W van NordenSee the full list of authors
30 December 2023
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriersDiane Beauvais, Céline Labeyrie, Cécile Cauquil, Bruno Francou, Ludivine Eliahou, Adeline Not, Andoni Echaniz-Laguna, Clovis Adam, Michel S Slama, Anouar Benmalek, Luca Leonardi, François Rouzet, David Adams, Vincent Algalarrondo, Guillemette Beaudonnet
24 October 2023
Impact of previous treatment history and B-cell depletion treatment duration on infection risk in relapsing-remitting multiple sclerosis: a nationwide cohort studySuvi Virtanen, Fredrik Piehl, Thomas Frisell
14 May 2024